News
Topics
Dr. Takakuwa from Translational Research Business Unit to present a poster at the 11th Annual Meeting of Nucleic Acids Therapeutics Society of Japan
Dr. Takakuwa, a researcher from the Translational Research Business Unit, will have a poster presentation at the...
Researcher Yuka Hasegawa from the Translational Research Business Unit to present a poster at the 53rd Annual Meeting of the Japanese Society of Toxicology
Yuka Hasegawa, a researcher from the Translational Research Business Unit, will have an oral and a poster...
Dr. Qinge Liang, a researcher from the Translational Research Business Unit, will have an oral and a poster presentation at the 53rd Annual Meeting of the Japanese Society of Toxicology
Dr. Qinge Liang, a researcher from the Translational Research Business Unit, will have an oral and a...
Researcher Furukawa from the Discovery Technologies Business Unit to present a poster at the 53rd Annual Meeting of the Japanese Society of Toxicology (JSOT)
Researcher Furukawa from the Discovery Technologies Business Unit to present a poster at the 53rd Annual Meeting...
J-Pharma’s LAT1 Inhibitor JPH034 Initiates Phase 1 Clinical Trial in the United States – Axcelead DDP Supported Multiple IND-Enabling Studies –
J-Pharma Co., Ltd. (“J-Pharma”) has announced that dosing of the first subject has commenced in the Phase...